Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery

Biochemistry

Volumn 53, Issue 24, 2014, Pages 4034-4046

  Qian, Ziqing ^a   Larochelle, Jonathan R ^b   Jiang, Bisheng ^a   Lian, Wenlong ^a   Hard, Ryan L ^a   Selner, Nicholas G ^a   Luechapanichkul, Rinrada ^a   Barrios, Amy M ^c   Pei, Dehua ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; MOLECULAR BIOLOGY; MOLECULES; PHOSPHOLIPIDS;

CELL-PENETRATING PEPTIDE; ENDOSOMAL ESCAPES; GENETIC MUTATIONS; HUMAN CANCER CELLS; MAMMALIAN CELLS; MEMBRANE PHOSPHOLIPIDS; PHARMACOLOGIC AGENTS; SMALL MOLECULES;

PEPTIDES;

CELL PENETRATING PEPTIDE; CYCLOPEPTIDE; DYE; HEPTAPEPTIDE; MEMBRANE PHOSPHOLIPID;

ARTICLE; CELL FUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DEPHOSPHORYLATION; ENDOCYTOSIS; ENDOSOME; GENE MUTATION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL;

CARRIER PROTEINS; CELL-PENETRATING PEPTIDES; CYTOPLASM; CYTOSOL; DRUG DELIVERY SYSTEMS; ENDOSOMES; GENE PRODUCTS, TAT; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; OLIGOPEPTIDES; PEPTIDES, CYCLIC; TRANSPORT VESICLES;

EID: 84903178535     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi5004102     Document Type: Article

References (79)

1. Frankel, A. D. and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus Cell 55, 1189-1193
2. Green, M. and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein Cell 55, 1179-1188
3. Langel, Ü. (2011) Cell-penetrating peptides: Methods and protocols, p xv, Humana Press, New York.
4. Schmidt, N., Mishra, A., Lai, G. H., and Wong, G. C. (2010) Arginine-rich cell-penetrating peptides FEBS Lett. 584, 1806-1813
5. Futaki, S. (2005) Membrane-permeable arginine-rich peptides and the translocation mechanisms Adv. Drug Delivery Rev. 57, 547-558
6. Stewart, K. M., Horton, K. L., and Kelley, S. O. (2008) Cell-penetrating peptides as delivery vehicles for biology and medicine Org. Biomol. Chem. 6, 2242-2255
7. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating peptides: Tools for intracellular delivery of therapeutics Cell. Mol. Life Sci. 62, 1839-1849
8. Goun, E. A., Pillow, T. H., Jones, L. R., Rothbard, J. B., and Wender, P. A. (2005) Molecular Transporters: Synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging ChemBioChem 7, 1497-1515
9. Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., and Khavari, P. A. (2000) Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation Nat. Med. 6, 1253-1257
10. Nori, A., Jensen, K. D., Tijerina, M., Kopeckova, P., and Kopecek, J. (2003) Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells Bioconjugate Chem. 14, 44-50
11. Hoyer, J. and Neundorf, I. (2012) Peptide vectors for the nonviral delivery of nucleic acids Acc. Chem. Res. 45, 1048-1056
12. Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H., Inokuchi, H., Fujita, S., Hayakawa, T., Takeda, K., Hasegawa, M., and Nakanishi, M. (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 276, 26204-26210
13. Nakase, I., Akita, H., Kogure, K., Graslund, A., Langel, U., Harashima, H., and Futaki, S. (2012) Efficient Intracellular Delivery of Nucleic Acid Pharmaceuticals Using Cell-Penetrating Peptides Acc. Chem. Res. 45, 1132-1139
14. Andaloussi, S. E., Lehto, T., Mager, I., Rosenthal-Aizman, K., Oprea, I. I., Simonson, O. E., Sork, H., Ezzat, K., Copolovici, D. M., Kurrikoff, K., Viola, J. R., Zaghloul, E. M., Sillard, R., Johansson, H. J., Said Hassane, F., Guterstam, P., Suhorutsenko, J., Moreno, P. M., Oskolkov, N., Halldin, J., Tedebark, U., Metspalu, A., Lebleu, B., Lehtio, J., Smith, C. I., and Langel, U. (2011) Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo Nucleic Acids Res. 39, 3972-3987
15. Jeong, J. H., Mok, H., Oh, Y. K., and Park, T. G. (2009) siRNA conjugate delivery systems Bioconjugate Chem. 20, 5-14
16. Muratovska, A. and Eccles, M. R. (2004) Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett. 558, 63-68
17. Wadia, J. S. and Dowdy, S. F. (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer Adv. Drug Delivery Rev. 57, 579-596
18. Pooga, M., Kut, C., Kihlmark, M., Hallbrink, M., Fernaeus, S., Raid, R., Land, T., Hallberg, E., Bartfai, T., and Langel, U. (2001) Cellular translocation of proteins by transportan FASEB J. 15, 1451-1453
19. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: Delivery of a biologically active protein into the mouse Science 285, 1569-1572
20. Josephson, L., Tung, C. H., Moore, A., and Weissleder, R. (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates Bioconjugate Chem. 10, 186-191
21. Gupta, B., Levchenko, T. S., and Torchilin, V. P. (2005) Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides Adv. Drug Delivery Rev. 57, 637-651
22. Liu, J., Zhang, Q., Remsen, E. E., and Wooley, K. L. (2001) Nanostructured materials designed for cell binding and transduction Biomacromolecules 2, 362-368
23. Saar, K., Lindgren, M., Hansen, M., Eiriksdottir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., and Langel, U. (2005) Cell-penetrating peptides: A comparative membrane toxicity study Anal. Biochem. 345, 55-65
24. Suhorutsenko, J., Oskolkov, N., Arukuusk, P., Kurrikoff, K., Eriste, E., Copolovici, D. M., and Langel, U. (2011) Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo Bioconjugate Chem. 22, 2255-2262
25. Rueping, M., Mahajan, Y., Sauer, M., and Seebach, D. (2002) Cellular uptake studies with β-peptides ChemBioChem 3, 257-259
26. Cooley, C. B., Trantow, B. M., Nederberg, F., Kiesewetter, M. K., Hedrick, J. L., Waymouth, R. M., and Wender, P. A. (2009) Oligocarbonate molecular transporters: Oligomerization-based syntheses and cell-penetrating studies J. Am. Chem. Soc. 131, 16401-16403
27. Pham, W., Kircher, M. F., Weissleder, R., and Tung, C. H. (2004) Enhancing membrane permeability by fatty acylation of oligoarginine peptides ChemBioChem 5, 1148-1151
28. Herce, H. D. and Garcia, A. E. (2007) Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes Proc. Natl. Acad. Sci. U.S.A. 104, 20805-20810
29. Hirose, H., Takeuchi, T., Osakada, H., Pujals, S., Katayama, S., Nakase, I., Kobayashi, S., Haraguchi, T., and Futaki, S. (2012) Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells Mol. Ther. 20, 984-993
30. Herce, H. D., Garcia, A. E., Litt, J., Kane, R. S., Martin, P., Enrigue, N., Rebolledo, A., and Milesi, V. (2009) Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides Biophys. J. 97, 1917-1925
31. Palm-Apergi, C., Lorents, A., Padari, K., Pooga, M., and Hallbrink, M. (2009) The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake FASEB J. 23, 214-223
32. Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., and Chernomordik, L. V. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 280, 15300-15306
33. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., and Beltram, F. (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time Mol. Ther. 8, 284-294
34. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins J. Biol. Chem. 278, 34141-34149
35. Kaplan, I. M., Wadia, J. S., and Dowdy, S. F. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis J. Controlled Release 102, 247-253
36. Nakase, I., Tadokoro, A., Kawabata, N., Takeuchi, T., Katoh, H., Hiramoto, K., Negishi, M., Nomizu, M., Sugiura, Y., and Futaki, S. (2007) Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis Biochemistry 46, 492-501
37. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 8, 848-866
38. Mueller, J., Kretzschmar, I., Volkmer, R., and Boisguerin, P. (2008) Comparison of cellular uptake using 22 CPPs in 4 different cell lines Bioconjugate Chem. 19, 2363-2374
39. Maiolo, J. R., Ferrer, M., and Ottinger, E. A. (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides Biochim. Biophys. Acta 1712, 161-172
40. El-Sayed, A., Futaki, S., and Harashima, H. (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment AAPS J. 11, 13-22
41. Varkouhi, A. K., Scholte, M., Storm, G., and Haisma, H. J. (2011) Endosomal escape pathways for delivery of biologicals J. Controlled Release 151, 220-228
42. Appelbaum, J. S., LaRochelle, J. R., Smith, B. A., Balkin, D. M., Holub, J. M., and Schepartz, A. (2012) Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm Chem. Biol. 19, 819-830
43. Qian, Z., Liu, T., Liu, Y. Y., Briesewitz, R., Barrios, A. M., Jhiang, S. M., and Pei, D. (2013) Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs ACS Chem. Biol. 8, 423-431
44. Lattig-Tunnemann, G., Prinz, M., Hoffmann, D., Behlke, J., Palm-Apergi, C., Morano, I., Herce, H. D., and Cardoso, M. C. (2011) Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides Nat. Commun. 2, 453
45. Mandal, D., Nasrolahi Shirazi, A., and Parang, K. (2011) Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters Angew. Chem., Int. Ed. 50, 9633-9637
46. Zhao, K., Choe, U. J., Kamei, D. T., and Wong, G. C. L. (2012) Enhanced activity of cyclic transporter sequences driven by phase behavior of peptide-lipid complexes Soft Matter 8, 6430-6433
47. Lian, W., Upadhyaya, P., Rhodes, C. A., Liu, Y., and Pei, D. (2013) Screening bicyclic peptide libraries for protein-protein interaction inhibitor: Discovery of a tumor necrosis factor-α antagonist J. Am. Chem. Soc. 135, 11990-11995
48. Mitra, S. and Barrios, A. M. (2005) Highly sensitive peptide-based probes for protein tyrosine phosphatase activity utilizing a fluorogenic mimic of phosphotyrosine Bioorg. Med. Chem. Lett. 15, 5124-5145
49. Stanford, S. M., Panchal, R. G., Walker, L. M., Wu, D. J., Falk, M. D., Mitra, S., Damle, S. S., Ruble, D., Kaltcheva, T., Zhang, S., Zhang, Z. Y., Bavari, S., Barrios, A. M., and Bottini, N. (2012) High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45 Proc. Natl. Acad. Sci. U.S.A. 109, 13972-13977
50. Yin, J., Straight, P. D., McLoughlin, S. M., Zhou, Z., Lin, A. J., Golan, D. E., Kelleher, N. L., Kolter, R., and Walsh, C. T. (2005) Genetically encoded short peptide tag for versatile protein labeling by Sfp phosphopantetheinyl transferase Proc. Natl. Acad. Sci. U.S.A. 102, 15815-15820
51. Holub, J. M., LaRochelle, J. R., Appelbaum, J. S., and Schepartz, A. (2013) Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics Biochemistry 52, 9036-6046
52. Huotari, J. and Helenius, A. (2011) Endosome maturation EMBO J. 30, 3481-3500
53. Rink, J., Ghigo, E., Kalaidzidis, Y., and Zerial, M. (2005) Rab conversion as a mechanism of progression from early to late endosomes Cell 122, 735-749
54. Yu, P., Liu, B., and Kodadek, T. (2005) A high-throughput assay for assessing the cell permeability of combinatorial libraries Nat. Biotechnol. 23, 746-751
55. Pratt, W. B. and Toft, D. O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones Endocr. Rev. 18, 306-360
56. Picard, D. and Yamamoto, K. R. (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor EMBO J. 6, 3333-3340
57. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., and Kirchhausen, T. (2006) Dynasore, a cell-permeable inhibitor of dynamin Dev. Cell 10, 839-850
58. Koivusalo, M., Welch, C., Hayashi, H., Scott, C. C., Kim, M., Alexander, T., Touret, N., Hahn, K. M., and Grinstein, S. (2010) Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling J. Cell Biol. 188, 547-563
59. Rodal, S. K., Skretting, G., Garred, O., Vilhardt, F., van Deurs, B., and Sandvig, K. (1999) Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles Mol. Biol. Cell 10, 961-974
60. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells J. Biol. Chem. 266, 17707-17712
61. Li, G., D'Souza-Schorey, C., Barbieri, M. A., Roberts, R. L., Klippel, A., Williams, L. T., and Stahl, P. D. (1995) Evidence for phophatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5 Proc. Natl. Acad. Sci. U.S.A. 92, 10207-10211
62. Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and Zerial, M. (1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis EMBO J. 13, 1287-1296
63. Rusnati, M., Tulipano, G., Spillmann, D., Tanghetti, E., Oreste, P., Zoppetti, G., Giacca, M., and Presta, M. (1999) Multiple interactions of HIV-1 Tat protein with size-defined heparin oligosaccharides J. Biol. Chem. 274, 28198-28205
64. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparin sulfate proteoglycans J. Biol. Chem. 276, 3254-3261
65. Ziegler, A. and Seelig, J. (2004) Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: Binding mechanism and thermodynamic parameters Biophys. J. 86, 254-263
66. Goncalves, E., Kitas, E., and Seelig, J. (2005) Binding of oligoarginine to membrane lipids and heparan sulfate: Structural and thermodynamic characterization of a cell-penetrating peptide Biochemistry 44, 2692-2702
67. Ziegler, A. (2008) Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans Adv. Drug Delivery Rev. 60, 580-597
68. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., and Mustellin, T. (2004) Protein tyrosine phosphatases in the human genome Cell 117, 699-711
69. Driggers, E. M., Hale, S. P., Lee, J., and Terrett, N. K. (2008) The exploration of macrocycles for drug discovery: An underexploited structural class Nat. Rev. Drug Discovery 7, 608-624
70. Marsault, E. and Peterson, M. L. (2011) Macrocycles are great cycles: Applications, opportunities, and challenges of synthetic macrocycles in drug discovery J. Med. Chem. 54, 1961-2004
71. Liu, T., Qian, Z., Xiao, Q., and Pei, D. (2011) High-throughput screening of one-bead-one-compound libraries: Identification of cyclic peptidyl inhibitors against calcineurin/NFAT interaction ACS Comb. Sci. 13, 537-546
72. Dewan, V., Liu, T., Chen, K. M., Qian, Z., Xiao, Y., Kleiman, L., Mahasenan, K. V., Li, C., Matsuo, H., Pei, D., and Musier-Forsyth, K. (2012) Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction ACS Chem. Biol. 7, 761-769
73. Wu, X., Upadhyaya, P., Villalona-Calero, M. A., Briesewitz, R., and Pei, D. (2013) Inhibition of Ras-effector interactions by cyclic peptides Med. Chem. Commun. 4, 378-382
74. Kwon, Y.-U. and Kodadek, T. (2007) Quantative comparison of the telative cell permeability of cyclic and linear peptides Chem. Biol. 14, 671-677
75. Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., and Lokey, R. S. (2006) Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers J. Am. Chem. Soc. 128, 2510-2511
76. Chatterjee, J., Gilon, C., Hoffman, A., and Kessler, H. (2008) N-Methylation of Peptides: A New Perspective in Medicinal Chemistry Acc. Chem. Res. 41, 1331-1342
77. Ren, L., Chen, X., Luechapanichkul, R., Selner, N. G., Meyer, T. M., Wavreille, A. S., Chan, R., Iorio, C., Zhou, X., Neel, B. G., and Pei, D. (2011) Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2 Biochemistry 50, 2339-2356
78. LaMontagne, K. R., Jr., Hannon, G., and Tonks, N. K. (1998) Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of Rat-1 fibroblasts and promotes differentiation of K562 cells Proc. Natl. Acad. Sci. U.S.A. 95, 14094-14099
79. Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., and Vogel, H. J. (2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs PLoS One 5, e12684